Point72 Asset Management, L.P. reports

Company location: Stamford, CT
Fiscal year end: 31 December

Point72 Asset Management, L.P. has filed 1,033 SEC EDGAR filings since 08 Apr 2014

Filter by type:
SC13D
SC13G

SEC filing history

Showing 301-325 of 1,000 matching filings.

Per page

25

Current page

13

SC 13G/A

CELLDEX THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MADISON SQUARE GARDEN ENTERTAINMENT CORP.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

TPI COMPOSITES, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A filing

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A filing

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

CYBIN INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

HEALTH CATALYST, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A filing

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

COGENT BIOSCIENCES, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ELEVATION ONCOLOGY, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MARINUS PHARMACEUTICALS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

GRITSTONE BIO, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

FIBROGEN, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

EOS ENERGY ENTERPRISES, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

CIDARA THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

AVALO THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ANAPTYSBIO, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

VISTAGEN THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

FARFETCH LIMITED

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

PROTAGONIST THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

AMYLYX PHARMACEUTICALS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SEMTECH CORPORATION

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SYNDAX PHARMACEUTICALS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

BIOHAVEN LTD.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

BIONOMICS LIMITED

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .